Molecular Mechanisms of Alcoholic Liver Disease: Innate Immunity and Cytokines

Alcoholism: Clinical and Experimental Research

Volumn 35, Issue 5, 2011, Pages 787-793

  Miller, Andrew M ^a   Horiguchi, Norio ^a,b   Jeong, Won Il ^a,c   Radaeva, Svetlana ^a   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b GUNMA UNIVERSITY   (Japan)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Alcohol liver injury; IFN ; IL 6; NK cells; STAT3

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; CHRONIC LIVER DISEASE; CONFERENCE PAPER; FATTY LIVER; INNATE IMMUNITY; KUPFFER CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; CYTOKINES; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-6; LIVER DISEASES, ALCOHOLIC; STAT3 TRANSCRIPTION FACTOR;

EID: 79955462788     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2010.01399.x     Document Type: Conference Paper

References (73)

1. Ahlenstiel G, Titerence RH, Koh C, Edlich B, Feld JJ, Rotman Y, Ghany MG, Hoofnagle JH, Liang TJ, Heller T, Rehermann B (2010) Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 138(1):325-335 e1-2.
2. Arteel GE (2003) Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124(3):778-790.
3. Breitkopf K, Nagy LE, Beier JI, Mueller S, Weng H, Dooley S (2009) Current experimental perspectives on the clinical progression of alcoholic liver disease. Alcohol Clin Exp Res 33(10):1647-1655.
4. Chen J, Bao H, Sawyer S, Kunos G, Gao B (1997) Effects of short and long term ethanol on the activation of signal transducer and activator transcription factor 3 in normal and regenerating liver. Biochem Biophys Res Commun 239(3):666-669.
5. Chen J, Clemens DL, Cederbaum AI, Gao B (2001) Ethanol inhibits the JAK-STAT signaling pathway in freshly isolated rat hepatocytes but not in cultured hepatocytes or HepG2 cells: evidence for a lack of involvement of ethanol metabolism. Clin Biochem 34(3):203-209.
6. Cheng L, You Q, Yin H, Holt M, Franklin C, Ju C (2009) Effect of polyI:C cotreatment on halothane-induced liver injury in mice. Hepatology 49(1):215-226.
7. Cohen JI, Roychowdhury S, McMullen MR, Stavitsky AB, Nagy LE (2010) Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology 139(2):664-674.
8. Cook RT, Li F, Vandersteen D, Ballas ZK, Cook BL, LaBrecque DR (1997) Ethanol and natural killer cells. I. Activity and immunophenotype in alcoholic humans. Alcohol Clin Exp Res 21(6):974-980.
9. Cubero FJ, Nieto N (2006) Kupffer cells and alcoholic liver disease. Rev Esp Enferm Dig 98(6):460-472.
10. Cubero FJ, Urtasun R, Nieto N (2009) Alcohol and liver fibrosis. Semin Liver Dis 29(2):211-221.
11. El Kasmi KC, Smith AM, Williams L, Neale G, Panopoulos AD, Watowich SS, Hacker H, Foxwell BM, Murray PJ (2007) Cutting edge: a transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. J Immunol 179(11):7215-7219.
12. El-Assal O, Hong F, Kim WH, Radaeva S, Gao B (2004) IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver. Cell Mol Immunol 1(3):205-211.
13. Fernandez DTD, Tuma P (2009) Chronic alcohol consumption impairs STAT3 and STAT5B nuclear translocation in hepatocytes. Hepatology 50:626A-627A.
14. Fischer R, Cariers A, Reinehr R, Haussinger D (2002) Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells. Gastroenterology 123(3):845-861.
15. Fukumura A, Tsutsumi M, Tsuchishima M, Hayashi N, Fukura M, Yano H, Ozaki K, Takase S (2007) Effect of the inducer of interleukin-6 (ME3738) on rat liver treated with ethanol. Alcohol Clin Exp Res 31(1 Suppl):S49-S53.
16. Gao B (2004) Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure. Alcohol 34(1):59-65.
17. Gao B (2005a) Alcohol and hepatitis virus interactions in liver pathology. Comprehensive Handbook of Alcohol related Pathology 2:819-832.
18. Gao B (2005b) Cytokines, STATs and liver disease. Cell Mol Immunol 2(2):92-100.
19. Gao B (2010) NKG2D, its ligands, and liver disease-good or bad? Hepatology 51:8-11.
20. Gao B, Jeong WI, Tian Z (2008) Liver: an organ with predominant innate immunity. Hepatology 47(2):729-736.
21. Gao B, Radaeva S, Park O (2009) Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 86(3):513-528.
22. Guo J, Loke J, Zheng F, Hong F, Yea S, Fukata M, Tarocchi M, Abar OT, Huang H, Sninsky JJ, Friedman SL (2009) Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology 49(3):960-968.
23. Harrison-Findik DGL, Eroglu E (2009) Inflammation-mediated activation of liver hepcidin expression is suppressed by alcohol: role of STAT3 protein. Hepatology 50:867A.
24. Hibi M, Nakajima K, Hirano T (1996) IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 74(1):1-12.
25. Hill DB, D'Souza NB, Lee EY, Burikhanov R, Deaciuc IV, de Villiers WJ (2002) A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 26(1):74-82.
26. Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ (1992) Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 119(5):547-552.
27. Hoek JB, Pastorino JG (2002) Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 27(1):63-68.
28. Hong F, Kim WH, Tian Z, Jaruga B, Ishac E, Shen X, Gao B (2002) Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 21(1):32-43.
29. Hong F, Radaeva S, Pan HN, Tian Z, Veech R, Gao B (2004) Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 40(4):933-941.
30. Horiguchi N, Ishac EJ, Gao B (2007) Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activation. Alcohol 41(4):271-280.
31. Horiguchi N, Lafdil F, Miller AM, Park O, Wang H, Rajesh M, Mukhopadhyay P, Fu XY, Pacher P, Gao B (2010) Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice. Hepatology 51(5):1724-1734.
32. Horiguchi N, Wang L, Mukhopadhyay P, Park O, Jeong WI, Lafdil F, Osei-Hyiaman D, Moh A, Fu XY, Pacher P, Kunos G, Gao B (2008) Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 134(4):1148-1158.
33. Hou X, Zhou R, Wei H, Sun R, Tian Z (2009) NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis. Hepatology 49(3):940-949.
34. Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, Kurt-Jones E, Szabo G (2008) The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48(4):1224-1231.
35. Huang H, Park PH, McMullen MR, Nagy LE (2008) Mechanisms for the anti-inflammatory effects of adiponectin in macrophages. J Gastroenterol Hepatol 23(Suppl 1):S50-S53.
36. Jaruga B, Hong F, Kim WH, Sun R, Fan S, Gao B (2004) Chronic alcohol consumption accelerates liver injury in T cell-mediated hepatitis: alcohol disregulation of NF-kappaB and STAT3 signaling pathways. Am J Physiol Gastrointest Liver Physiol 287(2):G471-G479.
37. Jeong WI, Park O, Gao B (2008) Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 134(1):248-258.
38. Jeong WI, Park O, Radaeva S, Gao B (2006) STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 44(6):1441-1451.
39. Kahraman A, Barreyro FJ, Bronk SF, Werneburg NW, Mott JL, Akazawa Y, Masuoka HC, Howe CL, Gores GJ (2008) TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. Hepatology 47(4):1317-1330.
40. Kahraman A, Schlattjan M, Kocabayoglu P, Yildiz-Meziletoglu S, Schlensak M, Fingas CD, Wedemeyer I, Marquitan G, Gieseler RK, Baba HA, Gerken G, Canbay A (2010) Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in non-alcoholic steatohepatitis. Hepatology 51(1):92-102.
41. Kano A, Wolfgang MJ, Gao Q, Jacoby J, Chai GX, Hansen W, Iwamoto Y, Pober JS, Flavell RA, Fu XY (2003) Endothelial cells require STAT3 for protection against endotoxin-induced inflammation. J Exp Med 198(10):1517-1525.
42. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134(4):657-667.
43. Lafdil F, Wang H, Park O, Zhang W, Moritoki Y, Yin S, Fu XY, Gershwin ME, Lian ZX, Gao B (2009) Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology 137(6):2125-2135 e1-2.
44. Mandal P, Park PH, McMullen MR, Pratt BT, Nagy LE (2010) The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat Kupffer cells. Hepatology 51(4):1420-1429.
45. Melhem A, Muhanna N, Bishara A, Alvarez CE, Ilan Y, Bishara T, Horani A, Nassar M, Friedman SL, Safadi R (2006) Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol 45(1):60-71.
46. Miller AM, Wang H, Park O, Horiguchi N, Lafdil F, Mukhopadhyay P, Moh A, Fu XY, Kunos G, Pacher P, Gao B (2010) Anti-inflammatory and anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver injury. Alcohol Clin Exp Res 34(4):719-725.
47. Minagawa M, Deng Q, Liu ZX, Tsukamoto H, Dennert G (2004) Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology 126(5):1387-1399.
48. Morishima C, Paschal DM, Wang CC, Yoshihara CS, Wood BL, Yeo AE, Emerson SS, Shuhart MC, Gretch DR (2006) Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 43(3):573-580.
49. Mosser DM, Zhang X (2008) Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226:205-218.
50. Nagy LE (2003) Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med (Maywood) 228(8):882-890.
51. Nemeth E, Baird AW, O'Farrelly C (2009) Microanatomy of the liver immune system. Semin Immunopathol 31(3):333-343.
52. Norkina O, Dolganiuc A, Catalano D, Kodys K, Mandrekar P, Syed A, Efros M, Szabo G (2008) Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes. Alcohol Clin Exp Res 32(9):1565-1573.
53. Norkina O, Dolganiuc A, Shapiro T, Kodys K, Mandrekar P, Szabo G (2007) Acute alcohol activates STAT3, AP-1, and Sp-1 transcription factors via the family of Src kinases to promote IL-10 production in human monocytes. J Leukoc Biol 82(3):752-762.
54. Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, Mavilio D, De Filippi F, Bruno S, Mondelli MU (2009) Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137(3):1151-1160.
55. O'Shea RS, Dasarathy S, McCullough AJ (2010) Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology 51(1):307-328.
56. Pan HN, Sun R, Jaruga B, Hong F, Kim WH, Gao B (2006) Chronic ethanol consumption inhibits hepatic natural killer cell activity and accelerates murine cytomegalovirus-induced hepatitis. Alcohol Clin Exp Res 30(9):1615-1623.
57. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B (2006) Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 130(2):435-452.
58. Radaeva S, Wang L, Radaev S, Jeong WI, Park O, Gao B (2007) Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. Am J Physiol Gastrointest Liver Physiol 293(4):G809-G816.
59. Rao R (2009) Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 50(2):638-644.
60. Rogers CQ, Ajmo JM, You M (2008) Adiponectin and alcoholic fatty liver disease. IUBMB Life 60(12):790-797.
61. Roychowdhury S, McMullen MR, Pritchard MT, Hise AG, van Rooijen N, Medof ME, Stavitsky AB, Nagy LE (2009) An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology 49(4):1326-1334.
62. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13(11):1324-1332.
63. Sermon F, Le Moine O, Gustot T, Quertinmont E, Louis H, Nagy N, Degraef C, Deviere J (2003) Chronic alcohol exposure sensitizes mice to galactosamine-induced liver injury through enhanced keratinocyte chemoattractant and defective IL-10 production. J Hepatol 39(1):68-76.
64. Shivakumar P, Sabla GE, Whitington P, Chougnet CA, Bezerra JA (2009) Neonatal NK cells target the mouse duct epithelium via Nkg2d and drive tissue-specific injury in experimental biliary atresia. J Clin Invest 119(8):2281-2290.
65. Siegmund SV, Dooley S, Brenner DA (2005) Molecular mechanisms of alcohol-induced hepatic fibrosis. Dig Dis 23(3-4):264-274.
66. Starkel P, De Saeger C, Leclercq I, Strain A, Horsmans Y (2005) Deficient Stat3 DNA-binding is associated with high Pias3 expression and a positive anti-apoptotic balance in human end-stage alcoholic and hepatitis C cirrhosis. J Hepatol 43(4):687-695.
67. Sun Z, Klein AS, Radaeva S, Hong F, El-Assal O, Pan HN, Jaruga B, Batkai S, Hoshino S, Tian Z, Kunos G, Diehl AM, Gao B (2003) In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 125(1):202-215.
68. Taimr P, Higuchi H, Kocova E, Rippe RA, Friedman S, Gores GJ (2003) Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 37(1):87-95.
69. Tsukamoto H, Lu SC (2001) Current concepts in the pathogenesis of alcoholic liver injury. FASEB J 15(8):1335-1349.
70. Wang H, Park O, Lafdil F, Shen K, Horiguchi N, Yin S, Fu XY, Kunos G, Gao B (2010) Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity. Hepatology 51(4):1354-1362.
71. Weng YI, Aroor AR, Shukla SD (2008) Ethanol inhibition of angiotensin II-stimulated Tyr705 and Ser727 STAT3 phosphorylation in cultured rat hepatocytes: relevance to activation of p42/44 mitogen-activated protein kinase. Alcohol 42(5):397-406.
72. Wiley TE, McCarthy M, Breidi L, Layden TJ (1998) Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 28(3):805-809.
73. Zhao XJ, Dong Q, Bindas J, Piganelli JD, Magill A, Reiser J, Kolls JK (2008) TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J Immunol 181(5):3049-3056.